Literature DB >> 8613537

Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.

J S Marshall1, I Leal-Berumen, L Nielsen, M Glibetic, M Jordana.   

Abstract

Mast cells have been implicated in a number of diseases involving chronic inflammation including asthma, rheumatoid arthritis, and inflammatory bowel diseases. They are a potent source of several cytokines, including IL-6 and TNF-alpha. Freshly isolated rat peritoneal mast cells will produce IL-6 in response to anti-IgE, LPS, PGE1, or PGE2; however, the mechanisms by which such cytokine production is regulated are poorly understood. IL-10 is recognized as an important immunoregulatory cytokine with effects on T cell development and the production of inflammatory cytokines. IL-10 has previously been described to enhance mast cell development in the context of IL-3 and IL-4. In the current study, we have examined the ability of IL-10 to modulate rat peritoneal mast cell IL-6 and TNF-alpha production in response to a variety of stimuli. We have observed that recombinant murine IL-10 can inhibit the production of both IL-6 and TNF-alpha by mast cells without altering the degree of histamine release in response to anti-IgE. Concentrations of IL-10 as low as 0.2 ng/ml were sufficient to inhibit IL-6 production by LPS- or anti-IgE-activated cells significantly. IL-10 also inhibited PGE1- and PGE2-induced IL-6 production. The relative potency of IL-10 as an inhibitor of mast cell IL-6 production was highly dependent upon the stimulus used, with a 10-fold difference in the IC50 for LPS- or anti-IgE-activated cells (0.21 ng/ml) and cells activated with a combination of LPS and PGE2 (2.29 ng/ml). This suggests that prostanoids may limit the ability of IL-10 to modulate mast cell IL-6 production in the context of inflammation. These data have important implications for the regulation of mast cell IL-6 in inflammatory diseases involving prostanoid production and the effects of treatment with cyclooxygenase inhibitors. Our results also demonstrate a dual role for IL-10 on mast cells as a growth factor and inhibitor of cytokine production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613537      PMCID: PMC507161          DOI: 10.1172/JCI118506

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions.

Authors:  A Wodnar-Filipowicz; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 2.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.

Authors:  M Plaut; J H Pierce; C J Watson; J Hanley-Hyde; R P Nordan; W E Paul
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells.

Authors:  W Northemann; T A Braciak; M Hattori; F Lee; G H Fey
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

7.  Activation of latent rheumatoid synovial collagenase by human mast cell tryptase.

Authors:  B L Gruber; L B Schwartz; N S Ramamurthy; A M Irani; M J Marchese
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

8.  Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation.

Authors:  A Wodnar-Filipowicz; C H Heusser; C Moroni
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

9.  Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines.

Authors:  P R Burd; H W Rogers; J R Gordon; C A Martin; S Jayaraman; S D Wilson; A M Dvorak; S J Galli; M E Dorf
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  40 in total

1.  Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damage.

Authors:  Michael G Haase; Anke Klawitter; Peter Geyer; Gustavo B Baretton
Journal:  J Histochem Cytochem       Date:  2007-08-06       Impact factor: 2.479

2.  ADAM10 is required for SCF-induced mast cell migration.

Authors:  Travis W Faber; Nicholas A Pullen; Josephine F A Fernando; Elizabeth Motunrayo Kolawole; Jamie J A McLeod; Marcela Taruselli; Kathryn L Williams; Kevin O Rivera; Brian O Barnstein; Daniel H Conrad; John J Ryan
Journal:  Cell Immunol       Date:  2014-05-21       Impact factor: 4.868

3.  Munc13 proteins control regulated exocytosis in mast cells.

Authors:  Elsa M Rodarte; Marco A Ramos; Alfredo J Davalos; Daniel C Moreira; David S Moreno; Eduardo I Cardenas; Alejandro I Rodarte; Youlia Petrova; Sofia Molina; Luis E Rendon; Elizabeth Sanchez; Keegan Breaux; Alejandro Tortoriello; John Manllo; Erika A Gonzalez; Michael J Tuvim; Burton F Dickey; Alan R Burns; Ruth Heidelberger; Roberto Adachi
Journal:  J Biol Chem       Date:  2017-11-15       Impact factor: 5.157

Review 4.  Mechanisms of interleukin-10-mediated immune suppression.

Authors:  C A Akdis; K Blaser
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

5.  Regular exercise modulates cardiac mast cell activation in ovariectomized rats.

Authors:  Sukanya Phungphong; Anusak Kijtawornrat; Jonggonnee Wattanapermpool; Tepmanas Bupha-Intr
Journal:  J Physiol Sci       Date:  2015-10-14       Impact factor: 2.781

Review 6.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

7.  IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma.

Authors:  Lixin Wang; Jin-Qing Liu; Fatemeh Talebian; Zhenzhen Liu; Li Yu; Xue-Feng Bai
Journal:  Oncoimmunology       Date:  2015-05-13       Impact factor: 8.110

8.  Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue.

Authors:  S C Bischoff; A Lorentz; S Schwengberg; G Weier; R Raab; M P Manns
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 9.  Stress triggers coronary mast cells leading to cardiac events.

Authors:  Michail Alevizos; Anna Karagkouni; Smaro Panagiotidou; Magdalini Vasiadi; Theoharis C Theoharides
Journal:  Ann Allergy Asthma Immunol       Date:  2013-10-10       Impact factor: 6.347

10.  IL-10 Enhances IgE-Mediated Mast Cell Responses and Is Essential for the Development of Experimental Food Allergy in IL-10-Deficient Mice.

Authors:  Stephanie H Polukort; Jeffrey Rovatti; Logan Carlson; Chelsea Thompson; Jennifer Ser-Dolansky; Shannon R M Kinney; Sallie S Schneider; Clinton B Mathias
Journal:  J Immunol       Date:  2016-05-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.